BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36504005)

  • 1. Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma.
    Gu L; Lin E; Liu S; Yang N; Kurtansky N; Neumann NM; Stoll J; Lezcano C; Pulitzer M; Noor S; Markova A; Rossi A; Dickson MA; Deng L
    J Med Virol; 2023 Jan; 95(1):e28396. PubMed ID: 36504005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod 5% Cream Versus Cryotherapy in Classic Kaposi Sarcoma.
    Odyakmaz Demirsoy E; Bayramgürler D; Çağlayan Ç; Bilen N; Şikar Aktürk A; Kıran R
    J Cutan Med Surg; 2019; 23(5):488-495. PubMed ID: 31072133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
    Célestin Schartz NE; Chevret S; Paz C; Kerob D; Verola O; Morel P; Lebbé C
    J Am Acad Dermatol; 2008 Apr; 58(4):585-91. PubMed ID: 18068265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation.
    Prinz Vavricka BM; Hofbauer GF; Dummer R; French LE; Kempf W
    Clin Exp Dermatol; 2012 Aug; 37(6):620-5. PubMed ID: 22300351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatments for Kaposi sarcoma: A systematic review.
    Htet KZ; Waul MA; Leslie KS
    Skin Health Dis; 2022 Jun; 2(2):e107. PubMed ID: 35677916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryotherapy, Imiquimod, and Electrochemotherapy Are Effective Options for Kaposi Sarcoma: A Call for Standardization to Allow for Comparisons and Informed Decisions.
    Curatolo P; Careri R; Simioni A; Campana LG
    J Cutan Med Surg; 2020; 24(2):218-219. PubMed ID: 32208013
    [No Abstract]   [Full Text] [Related]  

  • 7. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial.
    Tappero JW; Berger TG; Kaplan LD; Volberding PA; Kahn JO
    J Acquir Immune Defic Syndr (1988); 1991; 4(9):839-46. PubMed ID: 1895204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.
    Duvic M; Friedman-Kien AE; Looney DJ; Miles SA; Myskowski PL; Scadden DT; Von Roenn J; Galpin JE; Groopman J; Loewen G; Stevens V; Truglia JA; Yocum RC
    Arch Dermatol; 2000 Dec; 136(12):1461-9. PubMed ID: 11115156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for basal cell carcinoma of the skin.
    Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of effectiveness of cryotherapy on the treatment of cutaneous Kaposi's sarcoma.
    Kutlubay Z; Küçüktaş M; Yardımcı G; Engin B; Serdaroğlu S
    Dermatol Surg; 2013 Oct; 39(10):1502-6. PubMed ID: 23879208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
    Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
    Richel O; de Vries HJ; van Noesel CJ; Dijkgraaf MG; Prins JM
    Lancet Oncol; 2013 Apr; 14(4):346-53. PubMed ID: 23499546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
    Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
    J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
    Nahm WJ; Shen J; Zito PM; Gonzalez AM; Nagrani N; Moore K; Badiavas EV; Kirsner RS; Nichols AJ
    J Drugs Dermatol; 2021 Mar; 20(3):260-267. PubMed ID: 33683072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma in people living with HIV/aids in a public referral hospital in Peru.
    Mendoza Mori LM; Valenzuela Medina JB; Gotuzzo Herencia JE; Bravo Puccio FG; Mejía Cordero FA; Mohanna Barrenechea S; González Lagos EV
    Rev Peru Med Exp Salud Publica; 2022; 39(3):352-356. PubMed ID: 36478169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.
    Kreuter A; Rasokat H; Klouche M; Esser S; Bader A; Gambichler T; Altmeyer P; Brockmeyer NH
    Cancer Invest; 2005; 23(8):653-9. PubMed ID: 16377582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryotherapy Treatment of Cutaneous Kaposi Sarcoma in a Patient With B-Cell Chronic Lymphocytic Leukemia: A Case Report and Short Review of the Literature.
    Doupis J; Festas G; Tsekouras K; Seretis A; Fountzilas C
    Wounds; 2022 Jan; 34(1):E1-E6. PubMed ID: 35015695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
    Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
    Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
    Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
    AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial.
    Curatolo P; Quaglino P; Marenco F; Mancini M; Nardò T; Mortera C; Rotunno R; Calvieri S; Bernengo MG
    Ann Surg Oncol; 2012 Jan; 19(1):192-8. PubMed ID: 21822561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.